Drug prices in the United States are twice what they are in the United Kingdom and are much higher than in all other developed countries. In addition, drug prices are rising faster than prices for general consumer products or even other health care products. In this panel, Lisa Gill from Consumer Reports will describe the impact on patients. R. Adams Dudley, MD, from UCSF, will describe the consequences of high or expensive drug costs on patients with severe or chronic health conditions. Finally, Robin Feldman from UC Hastings will outline the role of patent law and market forces in driving prices higher. The panel and the audience will then discuss policy options to address high drug prices.
Video: UCSF Presentation by Lisa Gill and R. Adams Dudley, MD
Video: Capitol Insights: A UC Center Sacramento Panel Discussion
